EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, DexCom's enterprise value is €50,893 Mil.
DexCom's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €3,359 Mil. Therefore, DexCom's EV-to-Revenue for today is 15.15.
The historical rank and industry rank for DexCom's EV-to-Revenue or its related term are showing as below:
WBO:DXCM'
s EV-to-Revenue Range Over the Past 10 Years
Min: 5.49 Med: 14.92 Max: 29.64
Current: 14.97
During the past 13 years, the highest EV-to-Revenue of DexCom was 29.64. The lowest was 5.49. And the median was 14.92.
WBO:DXCM's EV-to-Revenue is ranked worse than 86.29% of 824
companies
in the Medical Devices & Instruments industry
Industry Median: 3.05
vs WBO:DXCM: 14.97
As of today (2024-04-25), DexCom's stock price is €128.64.
DexCom's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €7.93. Therefore, DexCom's PS Ratio for today is 16.21.
DexCom EV-to-Revenue Historical Data
The historical data trend for DexCom's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, DexCom's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DexCom's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, DexCom's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where DexCom's EV-to-Revenue falls into.
DexCom's current Enterprise Value is €50,893 Mil.
DexCom's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €3,359 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DexCom's share price for today is €128.64.
DexCom's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €7.93.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DexCom EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of DexCom's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
WBO:DXCM has been successfully added to your 